Dept of Neurology, Bispebjerg Hospital
Copenhagen, DK2400NV, Denmark
NCT Number: NCT01941732
Sildenafil (Viagra(R))is widely used by men with Parkinsons Disease (PD) and erectile dysfunction. A number of patients have reported that when they take Sildenafil, their need of anti-PD medication is reduced.
We hypotheses that sildenafil increases brain blood flow and hence improves the function of specific brain regions, improving motor function.
Motor function and cerebral blood flow of 8 patients will be tested before and after Sildenafil intake and before and after anti-PD medication.
Looking for future studies?
Notify Me18 year–80 year
Male
Interventional
Phase 4
Copenhagen, DK2400NV, Denmark
Erectile dysfunction can be experienced by up tp 40% of men with Parkinsons Disease (PD). Sildenafil (Viagra(R))is widely used by men with PD and erectile dysfunction. A number of patients have reported that when they take Sildenafil, their need of anti-PD medication is reduced.
We hypotheses that sildenafil increases cerebral blood flow in basal ganglia and hence improves the function, improving motor function.
Motor function and cerebral blood flow (rCBF) of 8 patients will be tested before and after Sildenafil intake and before and after anti-PD medication.
rCBF will be measured by the Xe133 inhalation method and a fast-rotating, brain-dedicated, single photon emission computerized tomograph (SPECT, Tomomatic, 232, Medimatic, Inc., Denmark). Two scans will be perfomed, when patients are i)in normal medicated state and ii) in normal medicated state 1 hour after intake of 100 mg sildenafil.
Motor function will be measured i 4 conditions: i)in normal medicated state and ii) in normal medicated state 1 hour after intake of 100 mg sildenafil, iii) after 12 hours of discontiation of anti-PD mediciation and iiii) after 14 hours of discontiation of anti-PD mediciation and 1 hour after intake of 100 mg sildenafil.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Sildenafil (Viagra (R)) 100 mg
Time frame: 1 hour
Motor function assessed by Unified Parkinsons disease Rating Scale, section 3 before and after challenge with Sildenafil and before and after discontinuation of anti-PD medication for 12 hours.
Time frame: 1 hour
change in rCBF in basal ganglia from before to 1 hour after intake of 100 mg of sildenafil
Bispebjerg Hospital
Other
Motor Response to Acute Challenge to Sildenafil in Parkinsons Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02126475
Basal Ganglia Diseases, Brain Diseases
Paris, France
View Trial DetailsNCT02676804
Basal Ganglia Diseases, Behavior
Charlottesville, Virginia, United States
View Trial DetailsNCT02092181
Basal Ganglia Diseases, Brain Diseases
Kirkland, Washington, United States
View Trial DetailsNCT01360229
Basal Ganglia Diseases, Brain Diseases
Aurora, Colorado, United States
View Trial Details